To Vape or Not to Vape

• Sponsor: Methodist Health System (Other)
• Overall Status: Terminated
• CT.gov ID: NCT05240027
• Collaborator: (none)
• Enrollment: 363
• Location: 1
• Arm: 1
• Actual Duration (Months): 11.5
• Patients Per Site Per Month: 31.6

Study Details

Study Description

Brief Summary

The overall goal of this study is to increase knowledge of vaping and its associated risks. This study will find the patterns of vaping, and how it all started among adolescents. Investigators want to know if students are aware of the serious and long term effects of vaping. This program titled, "To Vape or Not to Vape", will provide education to adolescents and young adults about the potential risk of vaping in an effort to assist with lowering the usage rates within the population. Content will include information about current statistics, potential short-term and long-term side-effects, and healthy alternatives for dealing with stress and peer-pressure. Investigators anticipate that this program will increase this population's knowledge about the risks of vaping products, and deter them from future use of the products. Effectiveness of this program will be measured by pre and post-tests. Investigators believe this program will make at least 50 percent of the participants more aware of the dangers and consequences of vaping, potentially lowering the rates of those participating in this habit while also preventing others from starting.

Condition or Disease	Intervention/Treatment	Phase
Vaping	Behavioral: Vape use survey	N/A

Detailed Description

The overall goal of this study is to increase knowledge of vaping and its associated risks. This study will find the patterns of vaping, and how it all started among adolescents. Investigators want to know if students are aware of the serious and long term effects of vaping. This program titled, "To Vape or Not to Vape", will provide education to adolescents and young adults about the potential risk of vaping in an effort to assist with lowering the usage rates within the population. Content will include information about current statistics, potential short-term and long-term side-effects, and healthy alternatives for dealing with stress and peer-pressure. Investigators anticipate that this program will increase this population's knowledge about the risks of vaping products, and deter them from future use of the products. Effectiveness of this program will be measured by pre and post-tests.

Study Design

• Study Type: Interventional
• Actual Enrollment: 363 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Other
• Official Title: To Vape or Not to Vape
• Actual Study Start Date: Mar 13, 2020
• Actual Primary Completion Date: Feb 26, 2021
• Actual Study Completion Date: Feb 26, 2021

Arms and Interventions

Arm

Intervention/Treatment

Other: Middle, High and College students within the Dallas-Fort Worth area that may Vape The program will be going to middle school, high school, and college campuses in the Dallas-Fort Worth (DFW) area to speak with students about vaping. The program will be implemented by community outreach, as the students will be presented with information about vaping and the resources necessary to prevent or stop vaping.

Behavioral: Vape use survey; pre & post test surveys

Outcome Measures

Primary Outcome Measures

1. percentage of vape users [The program will last 5 months between March 2020 and August 2020.]

   Investigators will obtain the percentage of vape users and their reasons for vaping from information gathered from (per-test questionnaire).

2. reasons for vaping [The program will last 5 months between March 2020 and August 2020.]

   Investigators will obtain the percentage of vape users and their reasons for vaping from information gathered from (per-test questionnaire).

Secondary Outcome Measures

1. Educational Effectiveness [The program will last 5 months between March 2020 and August 2020.]

   Changes in the degree of understanding will be assessed from the results of the pre and post-test (questionnaire).

Eligibility Criteria

Criteria

• Ages Eligible for Study: 12 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• The program's targeted population is starting at the middle school grade levels, up to college.

• Live in the DFW metroplex

• Willing to participate throughout the presentation

Exclusion Criteria:

• Less than 12 years old

• Students that are not in the DFW metroplex

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Methodist Dallas Medical Center	Dallas	Texas	United States	75203

Sponsors and Collaborators

• Methodist Health System

Investigators

• Principal Investigator: Maiya Bangurah, MBA, Methodist Health System Clinical Research Institute

Study Documents (Full-Text)

• Study Protocol and Statistical Analysis Plan - Feb 19, 2020

More Information

Publications

None provided.

• Responsible Party: Methodist Health System
• ClinicalTrials.gov Identifier: NCT05240027
• Other Study ID Numbers: 009.ONC.2020.D
• First Posted: Feb 15, 2022
• Last Update Posted: May 31, 2022
• Last Verified: May 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of May 31, 2022